Respiratory medicine

British Medical Journal

Volumn 323, Issue 7325, 2001, Pages 1349-1353

  Kerstjens, H A M ^a   Groen, J H ^a   Van der Bij, W ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; GLUCOCORTICOID;

ASTHMA; CANCER DIAGNOSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; GRAFT INFECTION; GRAFT REJECTION; HUMAN; LUNG CANCER; LUNG LOBECTOMY; LUNG TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SMOKING HABIT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG CONTRAINDICATION; LUNG DISEASE; LUNG RESECTION; LUNG TUMOR; TOMOGRAPHY; TREATMENT OUTCOME; UNNECESSARY PROCEDURE;

ASTHMA; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; LEUKOTRIENE ANTAGONISTS; LUNG DISEASES; LUNG NEOPLASMS; LUNG TRANSPLANTATION; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SUPPORT, NON-U.S. GOV'T; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; UNNECESSARY PROCEDURES;

EID: 0035830109     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
2. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease
3. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial
4. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease
5. Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease
6. Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema
7. Effect of lung-volume-reduction surgery in patients with severe emphysema
8. Prospective randomized trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease
9. Correlation of changes in quality of life after lung volume reduction surgery with changes in lung function, exercise, and gas exchange
10. Lung volume reduction surgery for emphysema: Out on a limb without a NETT
11. Equipoise and the ethics of the Canadian lung volume reduction surgery trial study: Should there be a randomized, controlled trial to evaluate lung volume reduction surgery?
12. Patients at high risk of death after lung-volume-reduction surgery
13. Self-management education and regular practitioner review for adults with asthma
14. Comparison of formoterol and terbutaline for as-needed treatment of asthma: A randomised trial
15. Leukotriene-receptor antagonists
16. Treatment of asthma with drugs modifying the leukotriene pathway
17. Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
18. Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial
19. Montelukast added to inhaled beclomethasone in treatment of asthma
20. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids
21. Treatment of aspirin-intolerant asthma with antileukotrienes
22. Treatment of allergic asthma with monoclonal anti-IgE antibody
23. Interleukin-4 receptor in moderate atopic asthma. A phase I/II randomized, placebo-controlled trial
24. Preoperative staging of non-small-cell lung cancer with positron-emission tomography
25. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging
26. Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients
27. An early comparison between endoscopic ultrasound-guided fine-needle aspiration and mediastinoscopy for diagnosis of mediastinal malignancy
28. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
29. The effect of lung transplantation on health-related quality of life: A longitudinal study
30. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs
31. Transplantation of lungs from a non-heart-beating donor
32. Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients